BCM
RGEN icon

BlueCrest Capital Management’s Repligen RGEN Stock Holding History

BlueCrest Capital Management’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-5,483
Closed -$289K – 1338
2018
Q4 		$289K Buy
5,483
+693
+14% +$40.6K 0.01% 521
2018
Q3 		$266K Buy
+4,790
New +$247K 0.01% 1101

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BlueCrest Capital Management's RGEN Position: Q1 2019 in Review

BlueCrest Capital Management sold out of Repligen (RGEN) in Q1 2019, closing a stake of 5,483 shares — an estimated $289K sold.

BlueCrest Capital Management first reported a position in RGEN in Q3 2018 and held it in 2 quarters. The position peaked at $289K in Q4 2018. 252 funds tracked by Wall St. Rank hold RGEN as of Q1 2019.

  • BlueCrest Capital Management reported no remaining Repligen position as of Q1 2019 after selling out during the quarter.
  • BlueCrest Capital Management sold 5,483 Repligen shares in Q1 2019, an estimated $289K.
  • BlueCrest Capital Management first reported a position in Repligen in Q3 2018 and held it in 2 quarters.
  • BlueCrest Capital Management's Repligen position peaked at $289K in Q4 2018.
  • 252 funds tracked by Wall St. Rank held Repligen as of Q1 2019.

Based on BlueCrest Capital Management's 13F filing for Q1 2019, filed 15 May 2019.